Innovative pharmaceutical sector weakens, Borui Pharmaceutical hits limit-down of 20%.

The innovative pharmaceutical sector fluctuated weaker, with Borui Pharma hitting a 20% drop limit, while Tailong Pharmaceuticals, Edan Pharmaceuticals, Yifang Bio, and Selon Pharmaceuticals followed suit.